|
Market Closed -
Nasdaq Stockholm
12:00:00 2026-11-17 pm EST
|
5-day change | 1st Jan Change | ||
| 0.7860 SEK | -7.53% |
|
-64.99% | -60.10% |
| Nov. 13 | Irlab narrows operating loss | FW |
| Nov. 13 | IRLAB Therapeutics AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2026 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| IRLAB THERAPEUTICS AB | Other Pharmaceuticals | -7.53% | -64.99% | -60.10% | -65.37% | -98.41% | 12.52M |
- Stock Market
- Stocks
- IRLAB A Stock
- Charts IRLAB Therapeutics AB
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
















